Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclodextrins in Parkinson's Disease.

Marisa C F Barros1,2, Ana C F Ribeiro3, Miguel A Esteso4

  • 1Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering, University of Alcalá, 28871 Alcalá de Henares, Madrid, Spain. marisa.barros@gmail.com.

Biomolecules
|December 26, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special Issue: Cyclodextrins: Properties and Applications, 2nd Edition.

International journal of molecular sciences·2025
Same author

Antibiotic-Cyclodextrin Interactions: An Effective Strategy for the Encapsulation of Environmental Contaminants.

Molecules (Basel, Switzerland)·2025
Same author

Study of the Thermodynamic Properties in Aqueous Solution of the Cyclocondensation Products of Pyrogallol and Propanaldehyde.

Molecules (Basel, Switzerland)·2025
Same author

Comparative Study of the Antioxidant Activity of the Conformers of <i>C</i>-tetra(4-methoxyphenyl)calix[4]resorcinarene.

International journal of molecular sciences·2024
Same author

On Interactions of Sulfamerazine with Cyclodextrins from Coupled Diffusometry and Toxicity Tests.

Biomolecules·2024
Same author

Transport Properties in Multicomponent Systems Containing Cyclodextrins and Nickel Ions.

International journal of molecular sciences·2024

This study investigates L-dopa and cyclodextrin interactions to improve Parkinson's disease treatments. Findings characterize molecular interactions for enhanced drug delivery systems.

Area of Science:

  • Physical Chemistry
  • Materials Science
  • Pharmacology

Background:

  • Parkinson's disease involves progressive neurodegeneration, with current treatments offering limited efficacy.
  • L-dopa is a primary treatment, but its delivery and effectiveness can be improved.
  • Cyclodextrins are explored for their potential in drug delivery systems.

Purpose of the Study:

  • To characterize thermodynamic and transport properties of L-dopa-cyclodextrin aqueous solutions.
  • To estimate L-dopa-cyclodextrin association constants using theoretical models.
  • To explore new controlled drug delivery systems for Parkinson's disease treatment.

Main Methods:

  • Studied binary and ternary aqueous solutions of L-dopa and cyclodextrins.
  • Measured thermodynamic properties (density, partial molar volume) and transport properties (diffusion coefficients, viscosity).
Keywords:
Parkinsoncontrolled drug delivery systemscyclodextrinsdensitylevodopamutual diffusion coefficientspartial molar volumesthermodynamic propertiestransport propertiesviscosity

Related Experiment Videos

  • Applied theoretical models to analyze experimental data and determine interaction parameters.

    • Main Results:

    • Determined L-dopa-cyclodextrin association constants, partial molar volumes, and expansibility.
    • Calculated thermodynamic parameters (Gibbs free energy, enthalpy, entropy) of interactions.
    • Characterized molecular interactions and structural features of potential drug delivery systems.

    Conclusions:

    • Provided insights into molecular interactions between L-dopa and cyclodextrins.
    • Identified structural characteristics of cyclodextrin-based drug delivery systems.
    • Highlighted the influence of cyclodextrin structure and temperature on L-dopa interactions for potential Parkinson's treatment enhancement.